EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC)

Horne, A., Brown, S., Butterworth, K. et al. (26 more authors) (2022) EP05.01-007 CONCORDE - A Phase Ib Platform Study of Novel Agents in COmbinatioN with COnventional RaDiothErapy in Non-small Cell Lung Cancer (NSCLC). Journal of Thoracic Oncology, 17 (9). s267-s268. ISSN 1556-0864

Metadata

Item Type: Article
Authors/Creators:
  • Horne, A.
  • Brown, S.
  • Butterworth, K.
  • Chalmers, A.
  • Collinson, F.
  • Dive, C.
  • Faivre-Finn, C.
  • Forster, M.
  • Franks, K.
  • Gilbert, A.
  • Hallam, M.
  • Hanna, G.
  • Harrow, S.
  • Hartley, J.
  • Hiley, C.
  • Jones, R.
  • Katona, E.
  • Kendall, J.
  • Krebs, M.
  • Mallison, G.
  • Oughton, J.B. ORCID logo https://orcid.org/0000-0002-2047-804X
  • Phillip, R.
  • Rothwell, D.
  • Sebag-Montefiore, D. ORCID logo https://orcid.org/0000-0002-5978-9259
  • Shaw, P.
  • Walls, G.
  • Walker, F.
  • Young, R.
  • Greystoke, A.
Keywords: Radiotherapy; DNA damage response inhibitors; Phase 1b trial
Dates:
  • Published: September 2022
  • Published (online): 8 September 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Medical Research (LIMR) > Division of Oncology
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Inst of Clinical Trials Research (LICTR) (Leeds)
Funding Information:
Funder
Grant number
Cancer Research UK Supplier No: 138573
C43923/A28890
Depositing User: Symplectic Publications
Date Deposited: 30 Jul 2024 18:33
Last Modified: 30 Jul 2024 18:33
Status: Published
Publisher: Elsevier
Identification Number: 10.1016/j.jtho.2022.07.453
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)